Completed
Effective cancer control options are available for some cancers, but these interventions remain inaccessible for many people in the world, especially those residing in low-resource communities. Disparities in cancer outcomes are also found in high-income countries—communities within wealthier nations, especially if they have challenges accessing cancer prevention and cancer care services. A major goal of the workshop was to encourage participants to share ideas about how to improve cancer treatment, palliative care, and survivorship care among low-resource settings both internationally and domestically..
Featured publication
Workshop
·2017
Though cancer was once considered to be a problem primarily in wealthy nations, low- and middle-income countries now bear a majority share of the global cancer burden, and cancer often surpasses the burden of infectious diseases in these countries. Effective low-cost cancer control options are avail...
View details
Description
An ad hoc committee will plan and host a 2-day public workshop to examine policy issues pertaining to the cancer care continuum in low resource areas, both domestic and international.
The second workshop will focus on cancer treatment, palliative care, and survivorship care in low-resource areas. The workshop will feature invited presentations and panel discussions on topics that may include:
- An overview of disparities in cancer control and outcomes, accounting for cultural and political barriers to access as well as resource-constraints
- The current evidence base and strategies to support effective cancer diagnosis and treatment in low-resource settings
- Key gaps in the evidence base and the challenges and opportunities to address those gaps to improve cancer outcomes for patients in low-resource populations
- Potential action steps for effectively applying the available evidence on cancer diagnosis and treatment in resource-constrained communities
The committee will develop the agenda for the workshop session, select and invite speakers and discussants, and moderate the discussions. An individually-authored workshop summary of the presentations and discussions at the workshop will be prepared by a designated rapporteur in accordance with institutional guidelines.
Collaborators
Committee
Robert W. Carlson
Co-Chair
Richard A. Larson
Co-Chair
Wendy Demark-Wahnefried
Member
Samir N. Khleif
Member
Mark Lazenby
Member
Greta Massetti
Member
Worta McCaskill-Stevens
Member
Loyce Pace
Member
Kathleen Schmeler
Member
Ya-Chen Tina Shih
Member
Lawrence N. Shulman
Member
Bhadrasain Vikram
Member
Sponsors
American Association for Cancer Research
American Cancer Society
American College of Radiology
American Society for Radiation Oncology
American Society of Clinical Oncology
American Society of Hematology
Association of American Cancer Institutes
AstraZeneca
Bristol Myers Squibb
Cancer Support Community
Centers for Disease Control and Prevention (CDC)
CEO Roundtable on Cancer
Flatiron Health
Helsinn Therapeutics (U.S.), Inc.
LiveSTRONG Foundation
Merck
National Comprehensive Cancer Network
National Institutes of Health/National Cancer Institute
Novartis Oncology
Oncology Nursing Society
Pfizer Inc.
Staff
Sharyl Nass
Lead
Cyndi Trang
Lead